Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?
about
Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological MethodsSplenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer.Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast CancerSarcoidosis with bone involvement mimicking metastatic disease at (18)F-FDG PET/CT: problem solving by diffusion whole-body MRI.Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells.Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis.
P2860
Q33875227-56703060-8BC8-4D54-8CA9-9A13877FC32FQ36256669-F3822851-EF2D-412E-B7DB-3808EE76D066Q36992942-AE72030F-74BA-400B-AAB9-75EF3627ABFAQ37146398-A5E235C3-3A3D-459F-A137-0B1D5576B43EQ38504136-37A93BBC-198D-4CB1-9195-CE6CC5E4F962Q47381221-98A52FC3-F758-40A8-815D-7F1ED6D3E145Q47547365-6C03AAF8-7F04-4A8E-B2BA-4640EBC9300E
P2860
Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Assessing response to treatmen ...... hould be the standard of care?
@en
type
label
Assessing response to treatmen ...... hould be the standard of care?
@en
prefLabel
Assessing response to treatmen ...... hould be the standard of care?
@en
P2093
P2860
P356
P1433
P1476
Assessing response to treatmen ...... hould be the standard of care?
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDU558
P577
2014-12-03T00:00:00Z